By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today reported that its first-quarter revenues increased around 4 percent.

The clinical lab giant, which has been adding molecular diagnostics and genetic testing assets over the past few years, had total revenues of $1.42 billion for the three-month period ended March 31 compared to $1.37 billion for Q1 2011. It beat analysts' consensus estimate for revenues of $1.40 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.